Implications of the FDA approval of PCSK9 inhibitors and FOURIER results for contemporary cardiovascular practice: An NCDR Research to Practice (R2P) project

Paul L. Hess, Kevin Kennedy, Michael Cowherd, Salim S. Virani, Frederick A. Masoudi, Ann Marie Navar, Robert W. Yeh, P. Michael Ho, Thomas M. Maddox

Research output: Contribution to journalLetterpeer-review

11 Citations (Scopus)
Original languageEnglish
Pages (from-to)151-152
Number of pages2
JournalAmerican Heart Journal
Publication statusPublished - Jan 2018
Externally publishedYes

Cite this